Myeloproliferative Neoplasms | Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting

Featuring perspectives from Dr Srdan Verstovsek, including the following topics: Overview of current issues in the management of myeloproliferative neoplasms (MPN) (0:00) Treatment strategies for patients with myelofibrosis (MF) progressing after ruxolitinib (14:46) Correlation of molecular characterization and response to ruxolitinib in patients with MF (23:57) Rationale for and efficacy with combined inhibition of Bcl-2 and Bcl-xL for MPN (44:38) Targeting calreticulin mutations for MPN (52:02) Advances in the management of polycythemia vera (57:54) Developments in the care of patients with essential thrombocythemia (1:04:43) Future directions in the clinical care of patients with MPN (1:12:46) CME information and select publications